VolitionRx Limited is a biotechnology company based in Belgium that focuses on the development and commercialization of tests based on epigenetic biomarkers for the diagnosis of various types of cancer and other diseases. Their main product is a test called Nu.QTM, which utilizes nucleosomal biomarker detection technology to determine the presence of cancer in the body. This test is designed to be non-invasive, reliable, and sensitive to various types of cancer, allowing for quick and accurate diagnosis. VolitionRx Limited aims to provide innovative diagnostic tools that can improve the detection of cancer and other diseases in early stages and contribute to better treatment and prognosis for patients.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
